AN ANIMAL MODEL OF NATURALLY OCCURRING TUMOR IMMUNITY
AN ANIMAL MODEL OF NATURALLY OCCURRING TUMOR IMMUNITY
批准号:
6522882
负责人:
Matthew L Albert
金额:
$4.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-08-15 至
关键词:
antitumor antibody autoimmunity autologous transplantation breast neoplasms cerebellar disorders cytotoxic T lymphocyte disease /disorder model enzyme linked immunosorbent assay genetically modified animals helper T lymphocyte laboratory mouse natural killer cells neoplasm /cancer immunology neuroimmunomodulation tumor antigens
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Paraneoplastic cerebellar degeneration (PCD) provides an important and unique example of naturally occurring breast tumor immunity in humans. PCD is characterized by a high titer antibody directed against a tumor antigen termed cdr2 that is normally expressed in the cerebellum. PCD patients develop an effective immune response to their tumors, and then come to clinical attention with severe neurologic dysfunction. It is proposed that the immune system initiates PCD when cdr2 is recognized as a foreign antigen in breast or ovarian tumors. We have hypothesized that the tumor immunity and neuronal destruction that occurs in PCD is not a result of antibodies against cdr2, but instead results from cytotoxic T cells (CTLs) that kill cdr2 expressing cells. This hypothesis is based in part on the failure of investigators to create an animal model of PCD by inducing cdr2 antibodies, and in part on our finding of cdr2-specific CTLs capable of killing tumors in PCD patients. We propose to test this hypothesis and deepen our understanding of breast tumor immunity by generating an animal model of PCD. Since we also find cdr2 expression in breast tumors obtained from neurologically normal individuals, our studies provide a new and important approach to breast cancer immunity in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECTIVE TUMOR IMMUNOTHERAPY IN TRANSITIONAL CELL CARCINOMA OF THE BLADDER
-
批准号:7207016
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2005
-
负责人:Matthew L Albert
-
依托单位:
Effective Tumor Immunotherapy in Transitional Cell Carc
-
批准号:7041514
-
项目类别:
-
资助金额:$0.69万
-
财政年份:2003
-
负责人:Matthew L Albert
-
依托单位:
AN ANIMAL MODEL OF NATURALLY OCCURRING TUMOR IMMUNITY
-
批准号:6402528
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:Matthew L Albert
-
依托单位:
AN ANIMAL MODEL OF NATURALLY OCCURRING TUMOR IMMUNITY
-
批准号:6209844
-
项目类别:
-
资助金额:$3.24万
-
财政年份:2000
-
负责人:Matthew L Albert
-
依托单位:
海外基金